Is KPRX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KPRX. It does not provide personalized investment advice.

KPRX (Kiora Pharmaceuticals, Inc. Common Stock) Stock Analysis - Financials

Kiora Pharmaceuticals, Inc. Common Stock (KPRX) is a publicly traded Healthcare sector company. As of October 29, 2026, KPRX trades at $2.20 with a market cap of $10.18M and a P/E ratio of -0.96. KPRX moved +0.00% today. Year to date, KPRX is +16.83%; over the trailing twelve months it is -3.87%. Its 52-week range spans $1.76 to $4.18. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces KPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are KPRX's key financials?

KPRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KPRX recently traded at $2.20. Market cap is $10.18M. P/E ratio is -0.96. Revenue is $0.

KPRX Key Metrics

Key financial metrics for KPRX
Metric	Value
Price	$2.20
Market Cap	$10.18M
P/E Ratio	-0.96
EPS	$-2.60
Dividend Yield	0.00%
52-Week High	$4.18
52-Week Low	$1.76
Volume	61.92K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-10.84M
Gross Margin	0.00%

KPRX Analyst Consensus

1 analysts cover KPRX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.

Common questions about KPRX

What are KPRX's key financials?: KPRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KPRX recently traded at $2.20. Market cap is $10.18M. P/E ratio is -0.96. Revenue is $0.
Is KPRX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KPRX. It does not provide personalized investment advice.